Alzheimer Disease Biomarkers and Assisted Dying
This Viewpoint discusses the expansion of blood-based biomarker testing for Alzheimer disease and outlines patient-physician communication strategies for end-of-life questions and physician-assisted death.
Original Source
Read the full article at Jamanetwork →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.